← Research library

Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke

Comparison in people · 2006

What was studied
Two comparative series: 35 patients in a Cortexin–Nootropil comparison and 45 in a Cortexin–Cerebrolysin comparison
Main finding
Authors described broadly similar clinical effects in moderate ischemic stroke and some practical advantages for Cortexin.

Reported findings and study design

Two comparative series: Cortexin versus Nootropil in 35 patients; Cortexin versus Cerebrolysin in 45 patients.

Population or model Two comparative series: 35 patients in a Cortexin–Nootropil comparison and 45 in a Cortexin–Cerebrolysin comparison

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Moderate-stroke clinical effectsDescribed as similar across the compared preparationsArm sizes, effect estimates and noninferiority margins absent

The two series and three preparations should not be treated as a single randomized ranking.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Allocation, masking and usable between-group effect estimates are unclear.
  • This is not a reliable head-to-head ranking or proof of equivalence.

Source details

Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.

Abstract reviewed

Sources checked

Citation

Human comparative studyEnglish abstract

Skorokhodov AP, Dudina AA, Kolesnikova EA, Koron AE, Kobantsev IuA, Sedova AA. Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 18193579

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards